FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

ULTRAGENYX PHARMACEUTICAL INC. — Operating Income by Fiscal Year

14 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/e0ead587-78d8-4a93-8c7f-70264640ad1b/serie/operating-income

Fiscal yearOperating IncomePeriodEvidence
FY 2025$-535.0M2025-01-01 – 2025-12-31evidence 0001193125-26-057329
FY 2024$-536.0M2024-01-01 – 2024-12-31evidence 0001193125-26-057329
FY 2023$-569.0M2023-01-01 – 2023-12-31evidence 0001193125-26-057329
FY 2022$-648.9M2022-01-01 – 2022-12-31evidence 0000950170-23-003096
FY 2021$-381.7M2021-01-01 – 2021-12-31evidence 0000950170-22-001284
FY 2020$-330.1M2020-01-01 – 2020-12-31evidence 0001564590-21-005610
FY 2019$-424.2M2019-01-01 – 2019-12-31evidence 0001564590-20-004667
FY 2018$-371.4M2018-01-01 – 2018-12-31evidence 0001564590-19-003324
FY 2017$-328.9M2017-01-01 – 2017-12-31evidence 0001564590-18-002535
FY 2016$-248.0M2016-01-01 – 2016-12-31evidence 0001564590-17-001714
FY 2015$-147.7M2015-01-01 – 2015-12-31evidence 0001564590-16-013430
FY 2014$-56.8M2014-01-01 – 2014-12-31evidence 0001564590-15-002066
FY 2013$-66.4M2010-04-22 – 2014-03-31evidence 0001564590-14-002047
FY 2012$-16.0M2012-01-01 – 2012-12-31evidence 0001564590-15-002066
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

ULTRAGENYX PHARMACEUTICAL INC. — all facts · Revenue · Net Income